Supply of CAR-T cell therapy active ingredients
Original notice title
GARA EUROPEA A PROCEDURA APERTA PER LA FORNITURA, IN ACCORDO QUADRO MULTIFORNITORE, DI PRINCIPI ATTIVI PER TERAPIE CON CELLULE CAR-T DESTINATE A PAZIENTI IN CARICO ALL’AZIENDA ULSS N. 8 BERICA
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
75 / 100
Risk factors
Need to register and become proficient with Sintel platform; possible technical issues.
ESPD may require detailed financial, technical, and capacity evidence not further specified.
Submission deadline in 12 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- EUR 19.4M estimated value
- Framework procurement
- Supplies contract
- 3 lots
- Duration 12 MONTH
- Supply of active principles for CAR-T cell therapies for patients under Azienda ULSS n. 8 Berica.
- Multi-supplier framework agreement for 12 months with possible 12-month renewal.
Show full summary
Open EU procedure for a multi-supplier framework agreement for the supply of active principles for CAR-T cell therapies to patients under Azienda ULSS N. 8 Berica. The tender is divided into 3 lots covering different lymphoma indications, with a total estimated value of €19,401,945. Submission is electronic via the Sintel platform, and the deadline is 26 July 2026. Award is based on price only. No procurement documents were analyzed; only the TED notice and structured data are available.
Risks
Need to register and become proficient with Sintel platform; possible technical issues.
ESPD may require detailed financial, technical, and capacity evidence not further specified.
Submission deadline in 12 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Administrative
- Registration on the Sintel electronic platform (ARIA SPA).
- Electronic submission only via Sintel.
- All documents and communication in Italian.
Requirements may be incomplete.
Award Criteria
Lot 1
Lot 2
Lot 3
Buyer
Name
AZIENDA ULSS N. 8 BERICA
Location
VICENZA, ITA
Buyer profile
Identifier
02441500242
Lots (3)
LOT-0001
LOTTO 1 - Terapia per pazienti adulti con Linfoma DLBCL - 2 Linea e Terapia per pazienti adulti con linfoma PMBCL - 3 linea
Therapy for adult patients with DLBCL (2nd line) and PMBCL (3rd line).
EUR 15.9M
Estimated value
Duration
Category
Selection criteria
Deadline
Award details
Value note
Framework maximum value
Show original TED data
Original TED description
LOTTO 1 - Terapia per pazienti adulti con Linfoma DLBCL - 2 Linea e Terapia per pazienti adulti con linfoma PMBCL - 3 linea
LOT-0002
LOTTO 2 - Terapia per pazienti adulti con Linfoma DLBCL - 3 Linea
Therapy for adult patients with DLBCL (3rd line).
EUR 1.7M
Estimated value
Duration
Category
Selection criteria
Deadline
Award details
Value note
Framework maximum value
Show original TED data
Original TED description
LOTTO 2 - Terapia per pazienti adulti con Linfoma DLBCL - 3 Linea
LOT-0003
LOTTO 3 - Terapia per pazienti adulti con Linfoma follicolare (LF) - 4 linea
Therapy for adult patients with follicular lymphoma (4th line).
EUR 1.7M
Estimated value
Duration
Category
Selection criteria
Deadline
Award details
Value note
Framework maximum value
Show original TED data
Original TED description
LOTTO 3 - Terapia per pazienti adulti con Linfoma follicolare (LF) - 4 linea
Procurement Details
- Publication date
- 28 May 2026
- Notice type
- Contract notice — standard
- Languages
- Italian
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 370198-2026
- Source notice ID
- 5b535d9a-fd33-45c2-8dd3-76995952a7e0
Documents (2)
Similar tenders
Poland – Antineoplastic agents – Dostawa produktów leczniczych i wyrobów medycznych do Wojskowego Instytutu Medycznego – PIB
Romania – Antineoplastic agents – achizitia de medicamente utilizate in tratamentul pacientilor beneficiari ai Programului Programului national de oncologie-Subprogramul de tratament medicamentos al bolnavilor cu afectiuni oncologice (adulti si copii), Programul national de oncologie medicamente COST-VOLUM
Poland – Immunoglobulins – Dostawy produktów leczniczych, wyrobów medycznych oraz substancji do receptury
Poland – Medicinal products for the blood, blood-forming organs and the cardiovascular system – Dostawa produktów leczniczych dla krwi, organów krwiotwórczych oraz układu krążenia, toksyn, środków leczniczych dla układu oddechowego, środków przeciwnowotworowych i immunomodulacyjnych stosowanych w ramach programów lekowych i chemioterapii, immunoglobulin oraz środków antywirusowych do użytku ogólnoustrojowego dla SPWSZ w Szczecinie
Slovakia – Antineoplastic and immunomodulating agents – Antineoplastické a imunomodulačné činidlá ( bežné )
Poland – Antineoplastic and immunomodulating agents – DOSTAWA LEKÓW ONKOLOGICZNYCH DLA WOJEWÓDZKIEGO SZPITALA SPECJALISTYCZNEGO IM. NAJŚWIĘTSZEJ MARYI PANNY W CZĘSTOCHOWIE
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
75 / 100
Risk factors
Need to register and become proficient with Sintel platform; possible technical issues.
ESPD may require detailed financial, technical, and capacity evidence not further specified.
Submission deadline in 12 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications